|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||2.01 - 2.11|
|52 Week Range||1.24 - 4.77|
|Beta (3Y Monthly)||0.93|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 7, 2018 - May 11, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.00|
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -22.22% and -10.87%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Richmond, California-based company said it had a loss of 11 cents per share. The robotic exoskeleton company posted revenue of $2.6 million in the period. In the final minutes of trading on Wednesday, ...
RICHMOND, Calif., Nov. 07, 2018 -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported.
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Thomas Schreck to its Board of Directors, effective immediately. “We are pleased to welcome Thomas to our Board,” said Steven Sherman, Chairman of the Board of Ekso Bionics. “With past successes in leading several pharmaceutical and medical device companies, Thomas brings a wealth of experience commercializing innovative solutions that align with our corporate strategy.
Ekso Bionics Holdings, Inc. (EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2018 after the close of trading on Wednesday, November 7, 2018. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. Investors interested in listening to the conference call may do so by dialing (877) 407-3036 for domestic callers or (201) 378-4919 for international callers. A live webcast of the event will be available in the “Investors” section of the company’s website at www.eksobionics.com, or by clicking here. A replay of the call will be available for two weeks by dialing (877) 660-6853 for domestic callers or (201) 612-7415 for international callers and using Conference ID: 13581989. The webcast will also be available on the company’s website for one month following the completion of the call.
If you own shares in Ekso Bionics Holdings Inc (NASDAQ:EKSO) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a Read More...
RICHMOND, Calif., Sept. 26, 2018-- Ekso Bionics Holdings, Inc., an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President and Chief Executive ...
German artificial limb manufacturer Ottobock (IPO-OBH.F) plans to start selling a mechanical exoskeleton that makes manual labor for factory workers easier this week, joining a field already crowded with major industrial players and start-ups. The family-owned company has tested the 'Paexo', a wearable upper-body exoskeleton designed to ease the physical strain of repetitive overhead assembly work, on 30 workers at a Volkswagen (VOWG_p.DE) plant in Bratislava. After 80 percent of workers said they would recommend it to colleagues, Ottobock is talking to Volkswagen about using the Paexo in series production, said Soenke Roessing, head of Ottobock's Industrials unit.
Junior miners turned lower in sympathy with declining gold and silver contracts, while small biotech and medical diagnostic stocks picked up the slack, underpinned by sector funds probing new highs. September has a mixed reputation when it comes to small speculative plays, suggesting that traders focus their attention on penny stocks exhibiting the highest relative strength while avoiding falling knives that may face tax selling pressure in the fourth quarter. Low-priced energy stocks look like wild cards in this equation, with crude oil coming off lows while rising Middle East tensions add to sector buying power.
NEW YORK, Aug. 22, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Evolent ...
Investors recently long EKSO have made 65% with more potential upside to come. Tandem Diabetes Care, Inc. (TNDM) has traded from $2 to $34/share this year, a gain of over 1700%. This is based on improving commercial success with their diabetes business and another FDA approval in the summer.
Shares of Ekso Bionics saw big gains during the trading day but lost almost 11% in after-hours trading. The company reported second quarter results that didn’t hit estimates. Spark Therapeutics, Inc. shares closed down 27.83% on Tuesday, on significant trading volume compared to usual.
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -18.18% and -2.08%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Richmond, California-based company said it had a loss of 13 cents. The robotic exoskeleton company posted revenue of $3 million in the period. In the final minutes of trading ...
Ford has rolled out a robotic vest for its factory workers that promises to lessen the physical toll that building cars and trucks takes on their bodies.
NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Ekso Bionics Holdings, Inc. (NASDAQ: EKSO ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern ...
The technology provides lift assistance to the arms to help reduce fatigue and injury risk. “Building vehicles is physically a tough job,” Bruce Hettle, Ford group vice president of Manufacturing and Labor Affairs, said in a press release. The Ford partnership was, in itself, big for Ekso.
On Tuesday, July 10, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Seven out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Medical Instruments & Supplies equities this morning: Becton, Dickinson and Co. (NYSE: BDX), Ekso Bionics Holdings Inc. (NASDAQ: EKSO), Haemonetics Corp. (NYSE: HAE), and Hologic Inc. (NASDAQ: HOLX).
Shareholder rights law firm Robbins Arroyo LLP reminds investors that purchasers of Ekso Bionics Holdings, Inc. filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 15, 2017 and December 27, 2017.